Valence Life Sciences is a private equity general partner firm headquartered in New York, NY, United States.
Invuity, a SF-based surgical photonics company, closed a $20m funding round from HealthCare Royalty Partners, InterWest Partners and ohers.
Invuity, a US-based advanced medical device developer, has raised $36m in Series E financing from Kleiner Perkins, InterWest and others.
Scott Morenstein and Jay Cecil have left Valence Life Sciences Investors to join Caxton Alternative Management.
Read more news concerning Valence Life Sciences
A sampling of Valence Life Sciences portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?